- Home
- /
- News
- /
- Target Identification/ Validation
- /
- June 2016
Target Identification/ Validation News for June 2016
MRC Technology (MRCT), a medical research charity, and AstraZeneca, a global biopharmaceutical company, are launching an initiative to find new epigenetic drug targets in respiratory disease. MRCT and AstraZeneca are now seeking academics with relevant epigenetics targets to collaborate with them to develop novel treatments for respiratory diseases, which affect millions of people every year.
15 June, 2016